PRESS RELEASE
BeiGene and Peregrine Market Access Win 2023 PM360 Pharma Choice Award
Saratoga Springs, NY, February 1, 2023—Peregrine Market Access, a full-service consulting, communications, and commercialization partner for the life sciences industry, today announced that its work in collaboration with BeiGene, a global biotechnology company, has earned industry recognition for marketing excellence. Specifically, BeiGene’s BTK Inhibitors AR Review entry has won the 2023 PM360 Silver Pharma Choice Award in the Sales Aid category.
Each category’s winners were determined based on votes cast by peers within the industry who judged entries on content, format, creativity, impactful messaging, and overall quality. The winning work is featured in the January/February 2023 issue of PM360.
“Our winning digital Visual Aid is an effective tool to help our account directors share key data and value messaging with market access customers about BRUKINSA®, a second-generation Bruton tyrosine kinase (BTK) inhibitor,” explained Steve Harris, director, Market Access Strategic Marketing at BeiGene USA, Inc. “Receiving this industry recognition is especially gratifying.”
“This honor is a reflection of our talented team and the collaborative nature we have with our clients to clearly communicate the value of their products,” said John Guarino, president and managing partner at Peregrine Market Access. “Our strength comes from having subject matter experts working in tandem with experienced creative professionals to help effectively communicate complex messages.”
In total, 42 winners were named in 14 distinct categories: App, Consumer Website, DTC/DTP, Multichannel, Multicultural, Philanthropic, Professional Print Campaign, Professional Website, Sales Aid, Self-promotion/Corporate Campaign, Social Media, Unbranded, Variety, and Video. A Gold, Silver, and Bronze award is given to the entries that receive the top three most votes in each category.
“The best critics are the people who understand your circumstances, challenges, and ultimately what it takes to be successful. In life sciences marketing, that description can only apply to other life sciences marketers, which is why we give each and every marketer in this industry the opportunity to decide what can be called the best campaigns of the year,” said Anna Stashower, chief executive officer, publisher, and editor-in-chief at PM360. “These winning campaigns and initiatives didn’t just leave an impression on their intended audience, but on the people in the industry responsible for creating them day in and day out.”
About Peregrine Market Access
Peregrine Market Access is a leading consulting, communications, and commercialization partner for the life sciences industry that’s on a mission to redefine the way healthcare is valued. The Peregrine group of companies includes the following: Communications Agency; Contract Account and Sales Team; Digital Modeling; Market Insights; Publication and Media Strategy; Reimbursement Solutions; Strategy and Consulting; and Value Chain Public Relations. Through its work with pharmaceutical and biotechnology clients, Peregrine helps people living with chronic and/or life-threatening conditions to gain access to FDA-approved diagnostics and treatments. Peregrine Market Access is nationally recognized as one of America’s fastest-growing private companies by Inc. 5000 and is certified as a Great Place to Work®. The company is headquartered in Saratoga Springs, New York, and also has an office in Santa Monica, California. Learn more at PeregrineMarketAccess.com.
About BeiGene
BeiGene is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. With a broad portfolio of more than 40 clinical candidates, BeiGene is expediting development of a diverse pipeline of novel therapeutics through its capabilities and collaborations. BeiGene and its growing global team of over 8,000 colleagues across five continents is committed to radically improving access to medicines for two billion more people by 2030. To learn more about BeiGene, please visit www.beigene.com.
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment. The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, public relations, and leadership. Visit https://www.pm360online.com/ to learn more.
Media Contact
Jenny Sparano
Vice President, Public Relations
[email protected]